Curious about people's thoughts re the timing of the release of the data given there were two or three patients in each trial unable to be assessed. Why not wait till full results? Perhaps they believed the bird in the hand was good not great but also not bad.
I'm guessing the conference side pushed thei hand, bit i just wonder about the value of publishing incomplete results that by all accounts could/should be more positive given the complete number of respondents being assessed.
I wonder if they risked doing another AIPAC if the market just read the headlines withour the disclainer of more to come.
i want to get excited with this nice consistent rise but it's just only getting back to the previous lows.. and I'm still almost break even, cant imagine you LTers.
encouraging progress !, page-21
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $581.0M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 41.5¢ | 39.5¢ | $1.576M | 3.906M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2506 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 8079 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |